Category Archives: Ulcerative Colitis

The global Inflammatory Bowel Disease Therapy market 2020 mainly focuses on the market trend, market share, size and forecast. It is a brief and professional analysis on the current scenario of the Global Inflammatory Bowel Disease Therapy market. The report on Inflammatory Bowel Disease Therapy market is a comprehensive study on global market analysis and insights. Continue reading →

Two administrations of cobitolimod 250 mg were well tolerated and efficacious in inducing clinical remission after 6 weeks in patients with moderate-to-severe, left-sided ulcerative colitis, according to findings from a new study. The topically administered, DNA-based oligonucleotide activates Toll-like receptor (9). Previous research has shown the therapy to be clinically efficacious in patients with moderate-to-severe ulcerative colitis The goal of this trial, dubbed the CONDUCT study, was to determine the most efficacious dose and dose regiment for further development. Continue reading →

In January 2015, I had emergency surgery to remove my large intestine after it perforated, and woke up with a stoma bag I had been living with undiagnosed ulcerative colitis (Picture: Hattie Gladwell) At the end of December, 2018, I woke up bloated and in pain. I desperately needed to go the toilet, but despite being just a few steps away from my bathroom, I couldnt do it. Next to me, in bed, was my date Continue reading →

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Carol Kwiatkowski, North Carolina State University (THE CONVERSATION) Like many inventions, the discovery of Teflon happened by accident. In 1938, chemists from Dupont (now Chemours) were studying refrigerant gases when, much to their surprise, one concoction solidified. Upon investigation, they found it was not only the slipperiest substance theyd ever seen it was also noncorrosive and extremely stable and had a high melting point Continue reading →

This transcript has been edited for clarity. David T Continue reading →

STOCKHOLM, Oct. 6, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the results of the CONDUCT study have been published in the high-impact medical journal The Lancet Gastroenterology and Hepatology. CONDUCT was a phase IIb dose optimisation study, evaluating the first-in-class TLR9 agonist cobitolimod for the treatment of moderate to severe ulcerative colitis Continue reading →

Sarah Smith always said she would rather die than have a stoma bag. After she was diagnosed with ulcerative colitis at 16, she battled painful and "embarrassing" symptoms with heavy medication for more than 10 years. Her condition, which causes the colon and rectum to become inflamed, meant she would regularly have to leave parties or meet-ups with friends suddenly to make sure she didn't have an "accident". Continue reading →

Oct. 2, 2020 10:59 UTC NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) today announced that the company will host a virtual Investor Event on Monday, October 12, 2020 at 8:00 a.m. EDT to discuss results from the Phase 3 True North trial evaluating Zeposia (ozanimod) in patients with moderate to severe ulcerative colitis, which will be presented at United European Gastroenterology (UEG) Week 2020 Continue reading →

Night of Steel Presented by UPMC and UPMC Health Plan HonorsLocal Volunteer, Rachel Stackiewicz, and Allegheny Health Network CEO, Cynthia Hundorfean The Crohns & Colitis Foundation Western Pennsylvania/West Virginia chapter invites the community to the third annual Night of Steel premier fundraising event on Saturday, Oct. Continue reading →

US Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Share & Trends Analysis Report by Disease Type (Ulcerative Colitis and Crohns Disease), By Treatment Type (Surgery and Anti- Inflammatory Drug Administration) and Forecast 2019-2025. The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. Continue reading →